Results 41 to 50 of about 16,457 (219)
Esophageal Pharmacobezoar in a Patient with Achalasia: A Case Report
Middle East Journal of Digestive Diseases, 2019 A few cases with esophageal bezoar have been reported in achalasia. We describe here a rare case of esophageal pharmacobezoar after ingestion of ferrous sulfate capsules in a patient with achalasia.
Hamid Tavakkoli
doaj +1 more source
Pediatric achalasia. Single-center study of interventional treatment
, 2016 Introduction: Esophageal achalasia is a rare entity in children. However, young age is a factor of failure of conservative treatment, emphasizing the role of surgery.
Michał Pasierbek +5 more
core +1 more source
Pediatric Hematology Oncology Journal, 2017 Introduction: Pseudo-achalasia (secondary achalasia): is a disorder produced by tumor at or near the gastro-esophageal junction, resulting in manifestation similar to those produced by achalasia.
Ramy Mohamed Ghazy
doaj +1 more source
, 2009 Achalasia is a disorder of esophageal motility characterized by esophageal aperistalsis and failure of the lower esophageal sphincter relaxation. The disease is progressive, resulting in gradual dilatation of the esophagus above the sphincter. Successful
Tam, PKH +3 more
core +1 more source
Translational Neuroscience, 2022 The precise pathogenesis of achalasia is still unclear. Neurodegenerative and/or demyelinating disorders (NDD) appear to share some common pathophysiological pathways described in achalasia such as inflammation, autoimmune, mitochondrial dysfunction, and
Khoury Salim T., Mari Amir
doaj +1 more source
World Journal of Surgery, EarlyView.Anastomotic leak and post‐operative pneumonia are major contributors to postoperative morbidity following esophagectomy and have traditionally led to delays in oral feed initiation. Newer evidence, however, suggests early initiation of feeds may be safe.
Debasri Jena +9 more
wiley +1 more source
Achalasia: current therapeutic options
, 2017 Achalasia is a chronic incurable esophageal motility disorder characterized by impaired lower esophageal sphincter (LES) relaxation and loss of esophageal peristalsis.
Madhusudhan R. Sanaka +2 more
core +1 more source
Validation of the Milan Score Using Prolonged Wireless PH Monitoring
Alimentary Pharmacology &Therapeutics, Volume 64, Issue 2, Page 177-185, July 2026.The Milan Score, a high‐resolution manometry‐derived tool, predicts pathological GERD on 96‐h wireless pH monitoring with high specificity and positive predictive value, maintaining robust discriminative performance across both typical and atypical symptom profiles and outperforming single HRM parameters as a standalone manometric parameter.
Stefano Siboni +8 more
wiley +1 more source
Peroral Endoscopic Myotomy: Establishing a New Program
, 2014 Achalasia is an esophageal motility disorder characterized by incomplete relaxation of the lower esophageal sphincter (LES) and aperistalsis of the esophageal body. Treatment of achalasia is aimed at decreasing the resting pressure in the LES.
Kumta, Nikhil A. +11 more
core +1 more source
Vigorous achalasia: Zebra amongst horses
South African Journal of Radiology, 2020 Vigorous achalasia is an oesophageal disorder with clinical and radiological characteristics of classic achalasia and diffuse oesophageal spasm. It is a rarely reported variant.
Jayaranjeetham Jayabalan +4 more
doaj +1 more source